RNA诱导基因沉默

RNA沉默在动植物进化中起着重要作用,具有抵抗病毒入侵、抑制转座子活动等作用,并调控蛋白编码基因的表达。该文着重对RNA沉默现象的作用机制和模式、功能及其应用前景作一综述。     

RNA:诱导基因沉默

在生物体中,双链RNA(double-strand RNA,dsRNA)裂解后的小RNA可以诱导细胞质和基因组水平外源基因沉默。所谓基因沉默(gene silencing)是指生物体中特定基因由于种种原因不表达。小RNA能诱导互补信使RNA在转录后降解。RNA沉默是基因组水平的免疫现象,代表了进化过程中原始的基因组对抗外源基因序列表达的保护机制,在动植物进化中起着重要作用,RNA沉默具有抵抗病毒入侵、抑制转座子活动等作用,并调控蛋白编码基因的表达,具有十分诱人的应用前景。     

植物RNA沉默机制的研究进展

RNA沉默是真核生物中普遍存在的抵抗病毒复制表达、抑制转座子转座及调控基因表达的监控机制。植物中的RNA沉默(转录水平的基因沉默PTGS)在RdRP的作用、transitive RNAi的双向延伸、沉默效应的系统性传播等方面与动物中有所不同,且植物中的内源性miRNA在数量和种类上也更具多样性。文中就以上方面及RNA沉默在植物中的应用进行了综述。     

RNA:诱导基因沉默

在生物体中 ,双链RNA (double strandRNA ,dsRNA)裂解后的小RNA可以诱导细胞质和基因组水平外源基因沉默。所谓基因沉默 (genesilencing)是指生物体中特定基因由于种种原因不表达。小RNA能诱导互补信使RNA在转录后降解 ,对于植物 ,可通过同源DNA序列甲基化使转录基因沉默。RNA沉默是基因组水平的免疫现象 ,代表了进化过程中原始的基因组对抗外源基因序列表达的保护机制 ,在动植物进化中起着重要作用 ,RNA沉默具有抵抗病毒入侵、抑制转座子活动、防止自私基因序列的过量增殖等作用 ,并调控蛋白编码基因的表达 ,具有十分诱人的应用前景     

植物RNA沉默的分子机制研究进展

RNA沉默（RNA silencing）是真核生物中的一种抵抗外源遗传因子（病毒、转座子或转基因）及调控基凶表达的防御机制。参与植物RNA沉默的酶及蛋白质主要包括6种RNA依赖的RNA聚合酶、4种Dicer-like（DCL）核酸内切酶和10种Argonautes蛋白。植物中4条RNA沉默途径分别由微小RNA（miRNAs）和3种小干扰RNA（siRNAs）介导,包括反式作用siRNAs（ta－siRNAs）、天然反义siRNAs（natsiRNAs）和异染色质siRNAs（hc-siRNAs）。在植物RNA沉默的系统性传播中,由DCL4或DCL2将dsRNAs裁剪为次级SiRNAS,以放大RNA沉默信号和增强沉默效应。     

RNA诱导沉默复合体中的生物大分子及其装配

在RNA干扰机制中,双链RNA诱导同源RNA降解的过程依赖于RNA诱导沉默复合体（RISC）的活性。RISC由Dicer酶,Argonaute蛋白,siRNA等多种生物大分子装配而成,对这些大分子的结构和功能进行深入细致的研究,有助于进一步了解RISC的形成过程、作用方式,以及阐明整个RNAi过程的作用机制。研究表明,RISC中的Dicer具有RNaseIII结构域,在RNAi的起始阶段负责催化siRNA的产生,在RISC装配过程中起稳定RISC中间体结构和功能的作用;Argonaute蛋白是RISC中的核心蛋白,有PAZ和PIWI两个主要的结构域,前者为siRNA的传递提供结合位点,后者是RISC中的酶切割活性中心;siRNA是RISC完成特异性切割作用的向导,在成熟的RISC中虽然只包含siRNA的一条链,但siRNA在RISC形成过程中的双链结构是保证RNAi效应的决定因素。尽管RISC中还存在其他一些功能未知的蛋白质,但在RISC组分结构及功能研究方面取得的进展为建立一个可能的RISC装配模型提供了理论基础。     

病毒编码的转录后沉默抑制蛋白

转录后水平沉默是植物体内天然存在的抗病毒防御机制,该机制基于双链RNA诱导的RNA干扰过程特异性降解植物病毒在体内复制时产生的双链RNA中间体,从而终止病毒的复制及扩散。而病毒在长期与植物体的互作进化过程中通过表达产生沉默抑制蛋白,也建立了针对寄主沉默机制的抗“防御”系统。     

RNA干涉及其应用前景

RNA干涉是指由特定双链RNA(dsRNA)引起的转录后基因沉默现象。研究表明,Dicer断裂dsRNA产生的小干涉RNA可以抑制哺乳动物体细胞和胚胎中的基因的表达。RdRP在扩增RNAi中起着关键性的作用,RdRP活性复制较长的触发性dsRNA或以一种非引物的方式复制短的siRNA,即以siRNA为引物的RdRP反应使靶mRNA转变为dsRNA,同时复制触发性dsRNA。所有的产物又可作为Dicer的底物,起始RdRP级联反应。本文综述了RNAi可能的作用机制,并对RNAi在分析功能基因组、药物治疗等方面的应用前景进行了展望。     

细菌非编码小RNA研究进展

细菌非编码小RNA(small non-coding RNA, sRNA)是一类长度在50~500个核苷酸, 不编码蛋白质的RNA。迄今, 在各种细菌中共发现超过150多种sRNA。它们通过碱基配对识别靶标mRNA, 在转录后水平调节基因的表达, 是细菌代谢、毒力和适应环境压力的重要调节因子。细菌sRNA的研究技术主要有基于生物信息学的计算机预测法和基于实验室的检测分析方法。这些方法所得到的sRNA都需要进行实验室确认, 然后再进一步通过各种实验手段研究其功能。     

Evolution and Diversification of RNA Silencing Proteins in Fungi

Comprehensive phylogenetic analyses of fungal Argonaute, Dicer, and RNA-dependent RNA polymerase-like proteins have been performed to gain insights into the diversification of RNA silencing pathways during the evolution of fungi. A wide range of fungi including ascomycetes, basidiomycetyes, and zygomycetes possesses multiple RNA silencing components in the genome, whereas a portion of ascomycete and basidiomycete fungi apparently lacks the whole or most of the components. The number of paralogous silencing proteins in the genome differs considerably among fungal species, suggesting that RNA silencing pathways have diversified significantly during evolution in parallel with developing the complexity of life cycle or in response to environmental conditions. Interestingly, orthologous silencing proteins from different fungal clades are often clustered more closely than paralogous proteins in a fungus, indicating that duplication events occurred before speciation events. Therefore, the origin of multiple RNA silencing pathways seems to be very ancient, likely having occurred prior to the divergence of the major fungal lineages. Electronic Supplementary Material Electronic Supplementary material is available for this article at and accessible for authorised users. [Reviewing Editor: Dr. Rüdiger Cerff]     

RNA干扰作用(RNAi)研究进展

RNA干扰作用 (RNAi)是生物界一种古老而且进化上高度保守的现象 ,是基因转录后沉默作用 (PTGS)的重要机制之一 .RNAi主要通过dsRNA被核酸酶切割成 2 1～ 2 5nt的干扰性小RNA即siRNA ,由siRNA介导识别并靶向切割同源性靶mRNA分子而实现 .RNAi要有多种蛋白因子以及ATP参与 ,而且具有生物催化反应特征 .RNAi是新发现的一种通过dsRNA介导的特异性高效抑制基因表达途径 ,在后基因组时代的基因功能研究和药物开发中具有广阔应用前景     

哺乳动物中RNA干扰沉默基因表达的研究进展

RNA干扰及相关基因沉默导致的代谢通路变化已经彻底改变了人们对基因调控的理解。基因沉默技术已经被用来作为一种研究工具来控制某些细胞基因的表达,特异的si RNA导入不同的细胞需要不同的转染载体才能达到最大的转染效率,并且不会产生较大的细胞毒性。近年来尤其是碳纳米管等新型纳米材料载体的应用拓展了人们对传统脂质体和病毒载体的认识。首先介绍RNA干扰技术及其发展历程,随后对利用几种不同的载体来设计和进行RNA干扰试验进行了比较,最后对最初的脂质体到生物病毒再到高分子纳米材料介导的RNA干扰在疾病的治疗和临床诊断进行了展望。     

RNA interference induced by siRNAs modified with 4'-thioribonucleosides in cultured mammalian cells

Short interfering RNAs (siRNAs) variously modified with 4'-thioribonucleosides against the Photinus luciferase gene were tested for their induction of the RNA interference (RNAi) activity in cultured NIH/3T3 cells. Results indicated that modifications at the sense-strand were well tolerated for RNAi activity except for full modification with 4'-thioribonucleosides. However, the activity of siRNAs modified at the antisense-strand was dependent on the position and the number of modifications with 4'-thioribonucleosides. Since modifications of siRNAs with 4'-thioribonucleosides were well tolerated in RNAi activity compared with that of 2'-O-methyl nucleosides, 4'-thioribonucleosides might be potentially useful in the development of novel and effective chemically modified siRNAs.     

MicroRNA-binding is required for recruitment of human Argonaute 2 to stress granules and P-bodies

Argonaute proteins are the core components of the RNA-induced silencing complex, the central effector of the mammalian RNA interference pathway. In the cytoplasm, they associate with at least two types of cytoplasmic RNA granules; processing bodies and stress granules, which function in mRNA degradation and translational repression, respectively. The significance of Argonaute association with these RNA granules is not entirely clear but it is likely related to their activities within the RNAi pathway. Understanding what regulates targeting of Argonautes to RNA granules may provide clues as to their functions at these organelles. To this end, there are a number of conflicting reports that describe the role of small RNAs in targeting Argonaute proteins in mammalian cells. We employed quantitative microscopic analyses of human Argonaute 2 (hAgo2) mutants to study factors that govern localization of this RNA-binding protein to cytoplasmic RNA granules. We report, for the first time, that hAgo2 is recruited to stress granules as a consequence of its interaction with miRNAs. Moreover, loading of small RNAs onto hAgo2 is not required for its stability, suggesting that a pool of unloaded hAgo2 may exist for extended periods of time in the cytoplasm.     

RNA helicase A is not required for RISC activity

It has been shown that siRNAs can compete with each other or with endogenous miRNAs for RISC components. This competition may complicate the interpretations of phenotypes observed through siRNA-mediated knockdown of genes, especially those genes implicated in the RISC pathway. In this study, we re-examined the function of RNA helicase A (RHA), which has been previously proposed to function in RISC loading based on siRNA-mediated knockdown studies. Here we show that reduced RISC activity or loading of siRNAs was observed only in cells depleted of RHA using siRNA, but not using RNaseH-dependent antisense oligonucleotides (ASOs), suggesting that the impaired RISC function stems from the competition between pre-existing and newly transfected siRNAs, but not from reduction of the RHA protein. This view is further supported by the findings that cells depleted of a control protein, NCL1, using siRNA, but not ASO, exhibited similar defects on the loading and activity of a subsequently transfected siRNA. Transfection of RHA or NCL1 siRNAs, but not ASOs, reduced the levels of endogenous miRNAs, suggesting a competition mechanism. As a positive control, we showed that reduction of MOV10 by either siRNA or ASO decreased siRNA activity, confirming its role in RISC function. Together, our results indicate that RHA is not required for RISC activity or loading, and suggest that proper controls are required when using siRNAs to functionalize genes to avoid competition effects.